Bionano Genomics (BNGO) Other Non Operating Income (2018 - 2026)

Bionano Genomics (BNGO) has 9 years of Other Non Operating Income data on file, last reported at -$619000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 112.19% year-over-year to -$619000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.9 million (down 176.31% YoY), and the FY2025 full-year result was $752000.0, up 1609.09% from the prior year.
• Other Non Operating Income grew to -$619000.0 in Q1 2026, from -$4.8 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $5.1 million in Q1 2025 to a low of -$20.2 million in Q4 2023.
• A 5-year average of -$1.2 million and a median of -$45000.0 in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income slumped 50307.5% in 2023 and jumped 473.25% in 2025, its largest moves.
• Tracing BNGO's Other Non Operating Income over 5 years: stood at -$40000.0 in 2022, then tumbled by 50307.5% to -$20.2 million in 2023, then jumped by 108.62% to $1.7 million in 2024, then plunged by 375.37% to -$4.8 million in 2025, then jumped by 87.07% to -$619000.0 in 2026.
• Business Quant data shows BNGO's Other Non Operating Income at -$619000.0 in Q1 2026, -$4.8 million in Q4 2025, and -$219000.0 in Q3 2025.